Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Halozyme Therapeutics (HALO)
Technical Analysis Report for USA stock HALO Halozyme Therapeutics. Dated: 20 Nov 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics then click here. or read Experts views on Halozyme Therapeutics or Forecast & share price targets of Halozyme Therapeutics
Halozyme Therapeutics Opened at 93.64 and Closed at: 91.35, which is -1.85% of previous session's close. It moved within a range of 90.79 and 93.64
The session was a Bearish session with an average volume of 1502800, which is -160.22% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 9 days back on short term averages
A Dead cross was found 6 days back on mid term averages
Support for tomorrow is 89.65 and resistance for tomorrow is 92.5
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 90.21, 89.08 resistance for tomorrow's hourly charts is 93.06, 94.78
10 Day SMA for Halozyme Therapeutics (HALO) is 98.12 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Halozyme Therapeutics (HALO) is 112.22 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Halozyme Therapeutics (HALO) is 113.21 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 103.19 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Halozyme Therapeutics is 85.97 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Halozyme Therapeutics is at 112.22 and 200 DMA is at 85.97, while 50 DMA and 100 DMA are at 113.21 and 103.19 respectively
Halozyme Therapeutics (HALO) moving average of 20 SMA is at 112.22 and 20 EMA is at 106.22
| Date | Closing Price | 20 SMA | 20 EMA |
| 20 Fri Nov | 91.35 | 112.22 | 106.22 |
| 19 Thu Nov | 93.04 | 113.93 | 107.79 |
| 18 Wed Nov | 95.80 | 115.5 | 109.34 |
| 17 Tue Nov | 95.97 | 116.96 | 110.76 |
| 16 Mon Nov | 96.50 | 118.38 | 112.32 |
| 13 Fri Nov | 100.27 | 119.68 | 113.98 |
Halozyme Therapeutics (HALO) moving average of 50 SMA is at 113.21 and 50 EMA is at 109.2
| Date | Closing Price | 50 SMA | 50 EMA |
| 20 Fri Nov | 91.35 | 113.21 | 109.2 |
| 19 Thu Nov | 93.04 | 113.53 | 109.93 |
| 18 Wed Nov | 95.80 | 113.81 | 110.62 |
| 17 Tue Nov | 95.97 | 114.04 | 111.22 |
| 16 Mon Nov | 96.50 | 114.29 | 111.84 |
| 13 Fri Nov | 100.27 | 114.56 | 112.47 |
Halozyme Therapeutics (HALO) moving average of 100 SMA is at 103.19 and 100 EMA is at 102.96
| Date | Closing Price | 100 SMA | 100 EMA |
| 20 Fri Nov | 91.35 | 103.19 | 102.96 |
| 19 Thu Nov | 93.04 | 103.07 | 103.19 |
| 18 Wed Nov | 95.80 | 102.91 | 103.4 |
| 17 Tue Nov | 95.97 | 102.74 | 103.55 |
| 16 Mon Nov | 96.50 | 102.55 | 103.7 |
| 13 Fri Nov | 100.27 | 102.33 | 103.85 |
Halozyme Therapeutics (HALO) moving average of 200 SMA is at 85.97 and 200 EMA is at 92
| Date | Closing Price | 200 SMA | 200 EMA |
| 20 Fri Nov | 91.35 | 85.97 | 92 |
| 19 Thu Nov | 93.04 | 85.92 | 92.01 |
| 18 Wed Nov | 95.80 | 85.85 | 92 |
| 17 Tue Nov | 95.97 | 85.76 | 91.96 |
| 16 Mon Nov | 96.50 | 85.66 | 91.92 |
| 13 Fri Nov | 100.27 | 85.55 | 91.87 |
Unitedhealth Group has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Unitedhealth Group, about 11.39% more returns!
Steris Plc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Steris Plc, about 39.78% more returns!
Perrigo Company has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Perrigo Company, about 29.4% more returns!
Johnson Johnson has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Johnson Johnson, about 30.18% more returns!
Sanofi has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Sanofi, about 39.96% more returns!
Pulmatrix Inc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Pulmatrix Inc, about 16.83% more returns!
Protagonist Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Protagonist Therapeutics, about 15.16% more returns!
Petmed Express has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Petmed Express, about 1.92% more returns!
Mesoblast has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Mesoblast, about 16.53% more returns!
Halozyme Therapeutics has performed better than Ionis Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Idexx Laboratories has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Idexx Laboratories, about 47.23% more returns!
Hutchison China has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Hutchison China, about 21.28% more returns!
Halozyme Therapeutics has performed better than Fate Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Cytomx Therapeutics has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Cytomx Therapeutics, about 20.08% more returns!
Cryolife Inc has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Cryolife Inc, about 9.82% more returns!
Aytu Bioscience has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Aytu Bioscience, about 66.46% more returns!
Halozyme Therapeutics has performed better than Autolus Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Align Technology has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Align Technology, about 30.55% more returns!
Halozyme Therapeutics Technical analysis of indicators
Price action analysis of Halozyme Therapeutics (HALO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 98.16 and Halozyme Therapeutics HALO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics HALO stock. Volume based technical analysis of Halozyme Therapeutics HALO stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And HALO Experts View which covers a lot of information including buying and selling signals
HALO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Halozyme Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


